Restor3d, a North Carolina-based innovator in 3D printed personalized orthopedic implants, has successfully raised $70 million in financing, despite a cooling interest from investors in the 3D tech startup sector.
The funding includes a $55 million Series A round led by Summers Value Partners, along with existing investors, and an additional $15 million in debt financing from Trinity Capital.
“This fundraising round reflects the strong confidence our investors have in Restor3d’s vision and potential,” stated CEO Kurt Jacobus. “With this capital, we can expedite our mission to revolutionize orthopedic care through 3D printed personalized implants.”
Restor3d is at the forefront of healthcare innovation, operating at the intersection of biotech, AI, and 3D technology. The company uses advanced biomaterials, 3D-printing technologies, and AI to develop implants designed to match the unique anatomy of individual patients. Their upcoming product launches include new implant systems for total ankle and shoulder replacements.
Founded in 2017, Restor3d has raised nearly $150 million to date, according to Crunchbase.
Decline in 3D Technology Funding
Restor3d’s recent funding marks a notable investment in the 3D technology sector, which has seen a significant decline in investment over the past two years.
While 2021 and 2022 saw substantial investments, the funding for VC-backed startups in the 3D technology sector decreased from over $2.4 billion in 2022 to approximately $1 billion last year, as per Crunchbase data. So far this year, the industry has only raised about $424 million.
Restor3d’s recent raise is the second largest in the industry this year, following Exodigo’s $75 million Series A in February, which focuses on subsurface image mapping solutions.
